Trusted for their quality, Safepac cartridges safeguard even the most sensitive GLP-1 formulations, from filling to final administration
Notes Text in parentheses is additional optional information which can be included on the label at the applicant's discretion
5 min read The FDA is putting its foot down on compounded GLP-1 drugswell, kind of
Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)
Over the years, he tried crash diets, like Atkins or intermittent fasting, and might drop 30 or 40 pounds, only to gain them back within a few months
Nevertheless, understanding GI adverse events across both earlier and newer GLP-1based therapies remains highly relevant, particularly as these agents are increasingly prescribed for long-term and off-label indications